Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / ADAR1 Capital Management, LLC
Form 13F · Q2 2026

ADAR1 Capital Management, LLC

CIK 1940272Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$2.2B
Reported book value
277
Positions
11
Quarters on record
Top 50
Positions

ADAR1 Capital Management, LLC — holdings

Top 50 positions of 277, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1ABIVAX SA Abivax Sa1.8M+29.5%$240M11.0%
2PTGX Protagonist Therapeutics Inc960,863−3.3%$118M5.4%
3ROIV Roivant Sciences Ltd3.2M−3.9%$112M5.1%
4SPY State Str Spdr S&P 500 Etf T129,087+70.0%$96M4.4%
5IMVT Immunovant Inc2.3M−13.0%$90M4.1%
6ZLAB Zai Lab Ltd3.4M+136.4%$64M2.9%
7AGIO Agios Pharmaceuticals Inc1.3M+815.6%$48M2.2%
8CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In1.2M+7.3%$46M2.1%
9EA SERIES TRUST Ea Series Trust337,125+0.0%$39M1.8%
10CYTK Cytokinetics Inc457,907−27.6%$39M1.8%
11SEPN Septerna Inc940,747−13.7%$32M1.4%
12AVR Anteris Technologies Global3.1M−17.0%$31M1.4%
13EDIT Editas Medicine Inc8.9M—$29M1.3%
14DNLI Denali Therapeutics Inc1.0M−45.0%$26M1.2%
15SYRE Spyre Therapeutics Inc283,982−16.1%$25M1.2%
16VIR Vir Biotechnology Inc2.5M−10.5%$25M1.1%
17PRAX Praxis Precision Medicines I74,253+4850.2%$25M1.1%
18INSM Insmed Inc228,520+545.7%$24M1.1%
19CLDX Celldex Therapeutics Inc New619,542+44.8%$23M1.1%
20VKTX Viking Therapeutics Inc574,038+152.1%$22M1.0%
21TSHA Taysha Gene Therapies Inc3.0M+2.0%$21M0.9%
22MNPR Monopar Therapeutics Inc217,595−17.7%$20M0.9%
23OVID Ovid Therapeutics Inc7.4M+63.2%$20M0.9%
24ELVN Enliven Therapeutics Inc387,718+17.7%$20M0.9%
25ENTA Enanta Pharmaceuticals Inc1.3M+2518.0%$20M0.9%
26NKTR Nektar Therapeutics244,184+51.4%$17M0.8%
27INSPIRE MED SYS INC Inspire Med Sys Inc374,617−7.5%$17M0.8%
28RVMD Revolution Medicines Inc87,509−34.6%$16M0.7%
29ESTA Establishment Labs Hldgs Inc185,619−13.0%$16M0.7%
30PRTA Prothena Corp Plc1.6M−1.7%$15M0.7%
31RYTM Rhythm Pharmaceuticals Inc136,158−35.6%$15M0.7%
32IKT Inhibikase Therapeutics Inc7.4M+11.8%$15M0.7%
33UNIQURE NV Uniqure Nv324,672+326.0%$15M0.7%
34RLYB Rallybio Corp926,352+4411.1%$15M0.7%
35REGN Regeneron Pharmaceuticals22,208+82.7%$14M0.6%
36IVA Inventiva Sa3.6M+65.9%$14M0.6%
37STRO Sutro Biopharma Inc404,014−23.0%$13M0.6%
38IONS Ionis Pharmaceuticals Inc166,286+3.7%$13M0.6%
39BBIO Bridgebio Pharma Inc176,689+87.4%$13M0.6%
40SRPT Sarepta Therapeutics Inc730,649+178.8%$13M0.6%
41CTMX Cytomx Therapeutics Inc.3.4M−1.3%$13M0.6%
42VOR Vor Biopharma Inc680,626—$13M0.6%
43SPDR SERIES TRUST Spdr Series Trust135,585+0.0%$12M0.6%
44EQ Equillium Inc3.8M+0.9%$12M0.6%
45ANL Adlai Nortye Ltd1.0M+763.2%$12M0.5%
46CLYM Climb Bio Inc822,649+37.6%$11M0.5%
47HLXC Helix Acquisition Corp Iii1.0M+0.0%$11M0.5%
48ZURA Zura Bio Ltd1.8M+179.1%$10M0.5%
49OKUR Onkure Therapeutics Inc2.2M−8.1%$10M0.5%
50MAZE Maze Therapeutics Inc339,276+577.3%$10M0.5%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.